1st International Congress of Vaccine and Vaccination (ICVV)

ICVV 2026 • CONGRESS SNAPSHOT

Congress at a Glance

Essential information about the 1st International Congress of Vaccine and Vaccination

Tehran

December 2026

Congress Dates

01 / 04

16–17 December 2026

Two-day international congress

Two days of scientific dialogue, collaboration, and professional networking

Venue

02 / 04

Milad Tower, Tehran

International Convention Center

One of Iran’s leading venues for scientific and international events

Scientific Focus

03 / 04

One Health and Vaccine Innovation

Science, technology, policy, access, and trust

From discovery and design to manufacturing, regulation, access, and public confidence

Grand Scientific Award

04 / 04

USD 20,000

ICVV Grand Scientific Award

Recognizing research and innovation with exceptional scientific and societal impact

Vaccine science, One Health, emerging technologies, and international collaboration

SCIENCE • INNOVATION • IMPACT

ICVV 2026 • SCIENTIFIC ARCHITECTURE

Scientific Architecture of the Congress

An integrated framework connecting One Health, scientific innovation, and the translation of vaccine knowledge into measurable health impact

SCIENTIFIC CORE

Science • Innovation • Impact

ICVV Scientific Vision

Building a Resilient Vaccine Ecosystem

ICVV does not view vaccine science as a collection of isolated subjects. Instead, it defines an interconnected pathway extending from scientific discovery and design to technology development, manufacturing, regulation, equitable access, and public trust.

Fundamental Research Technology Manufacturing Policy Health Impact

THREE SCIENTIFIC PILLARS

The Three Pillars of the ICVV Scientific Architecture

Three complementary domains supporting an integrated scientific, industrial, and societal ecosystem

PILLAR 01

01

One Health

HUMAN • ANIMAL • ENVIRONMENT

Integrating human, animal, and environmental health to strengthen prevention, surveillance, and coordinated responses to emerging diseases and biological threats.

Human Health Animal Health Environment

PILLAR 02

02

Science and Innovation

TECHNOLOGY • DATA • DISCOVERY

Advancing systems vaccinology, novel platforms, artificial intelligence, advanced biotechnology, and data analysis to accelerate vaccine discovery and development.

Novel Platforms Artificial Intelligence Data Analysis

PILLAR 03

03

From Discovery to Impact

MANUFACTURING • ACCESS • TRUST

Translating scientific findings into sustainable manufacturing, effective regulation, equitable access, social acceptance, and measurable health outcomes.

Manufacturing Regulation Equitable Access

THE ICVV IMPACT PATHWAY

Translating Science into Impact

STAGE 01

Scientific Discovery

Ideas, evidence, and research

STAGE 02

Technology Development

Design, evaluation, and optimization

STAGE 03

Manufacturing and Deployment

Scale, quality, and regulation

STAGE 04

Health Impact

Access, trust, and resilience

An integrated scientific architecture for a safer, fairer, and more resilient future

ONE HEALTH • INNOVATION • IMPACT

International Congress of Vaccine & Vaccination (ICVV)

ICVV convenes scientists, clinicians, manufacturers, investors, and policymakers to architect a resilient vaccine ecosystem for Iran and the region. Grounded in One Health and powered by data-driven technologies, the congress integrates discovery, translational development, scalable manufacturing, sustainable financing, and equitable public acceptance. The outcome is a shared roadmap for faster, safer, and fairer vaccination—within routine programs and during health emergencies.

Congress Key Topics

01

One-Health

Cross-sector surveillance, AMR stewardship, climate-aware risk dashboards, and mechanisms for real-time data sharing and surge coordination across borders.

02

Systems Vaccinology

Multi-omics + clinical integration to reveal correlates of protection, predict responders, and guide precision adjuvants, dosing, and schedules.

03

Vaccine Ecosystem Management: AI & Rapid Data

Digital twins for process control, real-time QC analytics, forecasting for demand/stock, and decision support for portfolio, trials, and rollout logistics.

04

Vaccination: From Access to Acceptance

Equitable procurement and last-mile delivery combined with behavioral insights, risk communication, and community engagement to build trust.

05

Novel Vaccine Platforms & Speed Development

mRNA/DNA, viral vectors, protein subunits, and novel delivery systems enabling rapid strain updates, thermostability innovation, and modular manufacturing.

06

Emerging Diseases & The 100-Day Vaccine Goal

Preparedness pipelines, prototype pathogens, and regulatory agility to compress design-to-deployment within 100 days of threat identification.

07

Veterinary Vaccines

Zoonoses control, livestock productivity, and One-Health-aligned platforms enhancing biosecurity and food system resilience.

08

Therapeutic Vaccines & Future Challenges

Cancer and NCD applications, neoantigen discovery, tolerogenic strategies, and combination therapies with biologics and cell-based platforms.

09

Financing Vaccine Innovation

Blended finance and prize/advance-purchase models that align public value, affordability, and private incentives for sustainable innovation.

10

Advanced Immunology & Immune Responses

Innate–adaptive crosstalk, germinal center dynamics, systems serology, and T/B repertoire analytics to define correlates and optimize adjuvants, dosing, and schedules.

11

Collaboration & Vaccine Diplomacy

Cross-border R&D networks, technology transfer, regulatory alignment, and equitable licensing/advance purchase to accelerate availability and shared resilience.

One Health, vaccine science, emerging technologies, and international collaboration

SCIENCE • VACCINES • ONE HEALTH

ICVV 2026 • IMPORTANT DATES

Important Congress Dates

Timeline for abstract submission and registration deadlines for the International Congress of Vaccine and Vaccination

TIMELINE

Abstracts • Registration

ABSTRACT SUBMISSION

Abstract Submission Deadlines

ABSTRACT SUBMISSION

01

First Abstract Submission Round

Until 22 July 2026

The first submission period for scientific abstracts.

ABSTRACT SUBMISSION

02

Second Abstract Submission Round

Until 22 September 2026

A second opportunity to complete and submit scientific abstracts.

FINAL DEADLINE

03

Final Abstract Submission Deadline

Until 6 November 2026

The final deadline for abstracts to enter scientific review.

REGISTRATION

Registration Deadlines

REGISTRATION

04

Early-Bird Registration

Until 22 July 2026

The early registration period with preferential conditions.

REGISTRATION

05

Standard Registration

Until 22 October 2026

The standard registration deadline for congress participants.

ON-SITE

06

On-Site Registration

16–17 December 2026

On-site registration during the two congress days.

Plan your scientific participation and registration for ICVV 2026

ABSTRACTS • REGISTRATION

ICVV 2026 • GRAND SCIENTIFIC AWARD

A Place for Bold Ideas; An Opportunity for Real Impact

ICVV 2026 Grand Scientific Award

Celebrating Excellence in Vaccine and Immunization Innovation

USD 20,000

Twenty Thousand US Dollars

The International Congress of Vaccine and Vaccination (ICVV 2026) proudly presents the Grand Scientific Award valued at USD 20,000 to recognize the most outstanding scientific innovations in vaccines and immunization. The award seeks to identify projects and ideas that combine rigorous scientific and methodological foundations with the potential to create lasting impact across the vaccine research and development ecosystem, with particular emphasis on the One Health approach.

View Award Details → ICVV 2026 • ONE HEALTH

GRAND SCIENTIFIC AWARD

USD 20,000

SCIENCE • INNOVATION • IMPACT

+

This grant is funded by philanthropists.

Supporting impactful research to strengthen the future of vaccine science and public health

SCIENCE • IMPACT • PHILANTHROPY

ICVV 2026 • EXHIBITION BOOTHS

Exclusive Opportunity to Reserve an Exhibition Booth

Limited Availability

A Strategic Presence at the Heart of the Vaccine Ecosystem

The ICVV specialized exhibition provides a focused platform for companies to present technologies, products, and capabilities directly to researchers, industry leaders, regulatory bodies, and health-sector decision-makers. It is designed to support meaningful engagement, commercial collaboration, and stronger connections between science, industry, and the market.

Technology Showcase Industry Networking B2B / B2G Market Development

Reserve a Booth / Send a Request → More Information

EXHIBITION BOOTH

Showcase. Connect. Grow.

INDUSTRY • INNOVATION • NETWORKING

Priority Areas

Which Companies and Technologies Are Prioritized?

01

Human and veterinary vaccines, vaccination, immunology, and biotechnology

02

Equipment, cold chain, transportation, packaging, and logistics

03

Laboratory services, quality control, diagnostic kits, and biological monitoring

04

Digital health systems, data analytics, and artificial intelligence

Technical booth specifications, sponsor packages, and participation terms are available on the exhibition information page.

Benefits of Participating

Why Is an ICVV Exhibition Booth Valuable?

+

Direct access to researchers, industry stakeholders, and regulatory bodies

+

B2B and B2G networking and targeted product exposure

+

Media visibility and opportunities to engage in specialized sessions

Booth capacity is limited. Requests will be reviewed according to submission time and relevance to the exhibition scope.

Contact and Requests: icvv1405@gmail.com

EXHIBITION • INDUSTRY • NETWORKING

0

Participants

0

Companies

0

Speakers

0

Panels

0

Papers

ICVV 2026 • OFFICIAL CONGRESS POSTER

Official Poster of the International Congress of Vaccine and Vaccination

Official poster of the ICVV 2026 International Congress of Vaccine and Vaccination

OFFICIAL VISUAL IDENTITY

Official ICVV 2026 Poster

View Full Poster Download Poster

Official poster featuring the final congress dates

OFFICIAL POSTER • FINAL DATES • ICVV 2026

Welcome Message

Welcome Message from Chairs

The President of the ICVV Congress

Message from the Presidency of the International Congress on Vaccines and Vaccination Congress President Executive Secretary Scientific Secretary Dr. Hasan morovati Congress President It is a great pleasure and an honor to serve as the Chair of the 1st....

The Scientific Secretary of ICVV

Message from the Presidency of the International Congress on Vaccines and Vaccination Scientific Secretary Congress President Executive Secretary Dr. Seyed Reza Bani Hashemi Scientific Secretary In a world where human, animal, and environmental health are increasingly intertwined, we believe that only through science, innovation, and interdisciplinary collaboration can we achieve a safer and more sustainable future. The First International Congress on Vaccines and Vaccination, with a focus on the One Health concept and the use of emerging technologies such as....

The Executive Secretary of ICVV

Message from the Presidency of the International Congress on Vaccines and Vaccination Executive Secretary Scientific Secretary Congress President Dr. Pejvak Khaki Executive Secretary It is my honor and privilege to welcome you to the 1st International Congress of Vaccine and Vaccination (ICVV 2026), to be held in April 2026 in Tehran, Iran. This congress will bring together leading scientists, industry experts, and policymakers from around the world to advance a modern vaccine ecosystem and to drive evidence-based innovation supporting global health security. The....

Keynote Speakers

Dr. Esmaeil Mortaz

Shahid Beheshti University of Medical....

Dr. Ali Akbar Mohammadi

Founder & CEO, GHSC, Switzerland

Prof. S. M. Mansour Haeryfar

Western University, Canada

Prof. Farhid Hemmatzadeh

The University of Adelaide, Australia

Dr. Ghobad Moradi

Ministry of Health and Medical....

Prof. Reza Nassiri

Michigan State University, USA

Dr. Andrew Lees

University of Maryland School of....

Dr. Masoud Solaymani Dodaran

Iran University of Medical Sciences

Prof. Mayyada Farhan Darweesh

University of Kufa, Iraq

Dr. Mohammad Mehdi Gouya

Head of the National Immunization....

Prof. Hamidreza Rabiee

Sharif University of Technology, Iran

Dr. Saeed Kalantari

Iran University of Medical Sciences,....

Prof. Osman Erganiş

Selçuk University, Konya, Turkey

Prof. Alireza Ranjbar

University of Bonn, Germany

Dr. Mojtaba Noofeli

Razi Vaccine and Serum Research....

View All

ICVV 2026 • VENUE & CITY EXPERIENCE

Congress Venue: Milad Tower, Tehran

Tehran: Where History, Science, and Urban Life Meet

Milad Tower: Host Venue of ICVV 2026

Tehran, Iran’s dynamic and multifaceted capital, brings together history, contemporary architecture, scientific institutions, museums, traditional bazaars, and modern urban spaces. At 435 metres, Milad Tower is one of the world’s tallest telecommunications towers and one of Tehran’s most recognizable landmarks. Its panoramic views of the city and the Alborz Mountains, accessible location, and integrated exhibition, cultural, and conference facilities make it a distinguished setting for an international scientific event.

Participation in ICVV 2026 extends beyond the scientific programme. Alongside the congress, delegates can experience selected dimensions of Tehran’s historical and cultural identity through landmarks such as Golestan Palace, the Sa’dabad Complex, and Tabiat Bridge.

MILAD TOWER • TEHRAN

Official Host Venue of ICVV 2026

SCIENCE • CITY • EXPERIENCE

DISCOVER TEHRAN

Selected Landmarks in Tehran

Four perspectives on the capital’s history, architecture, and urban life

Sa’dabad Historical and Cultural Complex

HERITAGE

Sa’dabad Complex

A historic complex in the northern foothills of Tehran

HISTORY

Golestan Palace

A landmark of the capital’s art, architecture, and history

VENUE

Milad Tower

A contemporary symbol of Tehran and the official congress venue

URBAN LIFE

Tabiat Bridge

A meeting point of contemporary architecture, nature, and urban life

Milad Tower • Official Venue

Coordinates: 35.74472, 51.37528

Google Maps Apple Maps

ICVV 2026 • OFFICIAL CHANNELS

Connect with ICVV

Click any logo to open the official channel.

Each link is attached directly to the logo itself.

DIRECT LINKS • NO POPUP TARGET

Congress News

Latest Congress News

Instructional Videos for Congress Registration and Abstract Submission Now Available

We are pleased to inform researchers, students, and participants of the 1st International Congress of Vaccine and Vaccination (ICVV) that....

“One Health and Biosecurity: The Need for a National Vaccine Ecosystem” Discussed on Keshik-e Salamat

Dr. Seyed Reza Banihashemi, Special Representative of the President for the National Vaccine Ecosystem, Scientific Secretary of the First....

August 27 - Pharmacist’s Day

August 27 marks Pharmacist’s Day in Iran, commemorating the birth anniversary of Muhammad ibn Zakariya al-Razi (Rhazes), one of the....

RAZI-COV PARS Highlights Iran’s Contribution to the Global Conversation on Next-Generation Mucosal Vaccines

Tehran – The recombinant RAZI-COV PARS COVID-19 vaccine, developed at the Razi Vaccine and Serum Research Institute, has been....

ICVV Statement on World Hepatitis Day: Advancing Global Immunization Strategies to Eliminate Viral Hepatitis by 2030

On the occasion of World Hepatitis Day (July 28th), the 1st International Congress of Vaccine and Vaccination (ICVV) reaffirms its commitment....

Content Production Working Group Meeting Held for ICVV 2026

As part of the planning and coordination of communication and media activities, a meeting of the Content Production Working Group of the First....

August 23 | Physician’s Day

On Physician’s Day, we honor the dedication, knowledge, and unwavering commitment of physicians who stand at the forefront of....

View All

ICVV 2026 • REGISTRATION & SPONSORSHIP

Registration Fees and Sponsorship Packages

Scientific Participation and Strategic Partnership

Choose the Right Path to Participate in ICVV 2026

The registration structure offers dedicated rates for Students, Delegates, and Oral / Poster Presenters. Early Bird registration provides the most advantageous fee and supports effective planning for participation in scientific sessions and educational workshops.

Sponsorship packages are designed for organizations and companies seeking meaningful visibility, engagement with scientific and industry communities, and a strategic role in the future of the vaccine ecosystem.

REGISTRATION & SPONSORSHIP

Participate. Support. Create Impact.

ACCESS • PARTNERSHIP • IMPACT

REGISTRATION FEES

Registration Fees

Early-Bird • Best Rate Standard On-site

Participant Category	Early-Bird	Standard	On-Site
Student	$149 EARLY BIRD	$199 STANDARD	$249 ON-SITE
Delegate	$199 EARLY BIRD	$249 STANDARD	$299 ON-SITE
Oral / Poster Presenter	$169 EARLY BIRD	$209 STANDARD	$259 ON-SITE

All fees are stated in US dollars (USD). Early Bird rates apply to registrations completed before the published deadline. Student status may be verified at check-in.

After completing registration, participation in educational workshops will be completely free of charge for all registered attendees.

SPONSORSHIP OPPORTUNITIES

Sponsorship Packages

View the Full Benefits Table

Silver Level

$1,500

USD

SILVER PARTNER

Gold Level

$2,500

USD

GOLD PARTNER

Diamond Level

$2,000

USD

DIAMOND PARTNER

Platinum Level

$2,500

USD

PLATINUM PARTNER

Pioneer Level

Contact Us

Custom Partnership Design

PIONEER PARTNER

Platinum Sponsors

Razi Vaccine & Serum Research Institute

Founded in 1925, Razi is Iran’s national producer of human- and veterinary-grade immunobiologics. Portfolio ~80 vaccines/sera plus large-volume antivenoms; part of AREEO (MAJ). Integrates discovery, process development, and GMP manufacturing; recent outputs include Razi Cov Pars and new biotech platforms.

Visit Website (Click header to close)

Pasteur Institute of Iran

Since 1920, a regional hub for vaccine R&D, biomedical sciences, and public-health training. Links basic research to pilot and biologics production; supports communicable-disease control, technology transfer, and workforce development.

Visit Website (Click header to close)

Ministry of Health and Medical Education (MOHME)

National authority for policy, regulation, service delivery, and medical education. Deputyships (Health, R&T, Education, Logistics, Food & Drugs) oversee the PHC network, universities, and the pharmaceutical sector. PHC backbone enables population programs, surveillance, and rapid incident response.

Visit Website (Click header to close)

Ministry of Agriculture Jahad (MAJ)

Leads ag policy, food security, and rural development via AREEO’s 19 institutes—linking labs, extension, and industry for improved varieties, animal-health solutions, and sustainable systems. Drives One-Health and climate-smart agriculture.

Visit Website (Click header to close)

Vice-Presidency for Science, Technology & Knowledge-Based Economy

Orchestrates the National Innovation System—policy, funding, and markets—to scale knowledge-based firms: commercialization, venture/credit tools, demand creation, exports, localization of strategic technologies, and international S&T outreach.

Visit Website (Click header to close)

Health Deputy (MOHME)

Operates Iran’s public-health and PHC platforms: immunization, surveillance, family-physician/health-network, and performance with universities. During emergencies, scales interventions via PHC and incident-command.

Visit Website (Click header to close)

AIA

AIA advances international collaboration among physicians and scientists through scientific meetings, continuing-education initiatives, and networking that bridges Europe and Iran—supporting translational medicine and public health.

Visit Website (Click header to close)

Professor Alireza Yalda Scientific Meeting

An AIA-hosted scientific forum honoring Prof. Alireza Yalda’s legacy in clinical medicine and education. The meeting convenes clinicians and researchers to exchange evidence, best practices, and innovations with public-health impact.

Visit Website (Click header to close)

Complete the One Health vaccine ecosystem

Place your logo here. ICVV connects scientists, manufacturers, regulators, and investors to co-design a resilient vaccine ecosystem. As a sponsor, your organization becomes a visible node in this network—shaping policy, innovation, and real-world impact.

B2B & B2G networking opportunities
High-visibility branding across ICVV channels
Access to expert panels & strategic sessions

Partner with us: icvv1405@gmail.com · More info: icvv.iranvaxhub.com

Become a Sponsor (Click header to close)

1st International Congress of Vaccine and Vaccination

Grand Scientific Award: Supporting Innovators; The Lasting Legacy of Donors

International Congress of Vaccine & Vaccination (ICVV)

0

0

0

0

0

Welcome Message

The President of the ICVV Congress

The Scientific Secretary of ICVV

The Executive Secretary of ICVV

Keynote Speakers

Congress News

Platinum Sponsors

Razi Vaccine & Serum Research Institute

Pasteur Institute of Iran

Ministry of Health and Medical Education (MOHME)

Ministry of Agriculture Jahad (MAJ)

Vice-Presidency for Science, Technology & Knowledge-Based Economy

Health Deputy (MOHME)

AIA

Professor Alireza Yalda Scientific Meeting

Complete the One Health vaccine ecosystem